United Therapeutics Corporation technical analysis
Technical analysis of United Therapeutics Corporation (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is United Therapeutics Corporation
United Therapeutics Corporation is a pharmaceutical company that develops and commercializes medicines to address chronic and life-threatening diseases, with a focus on pulmonary arterial hypertension, idiopathic pulmonary fibrosis, and high-risk neuroblastoma. Its product portfolio includes inhaled, oral, and injectable formulations, along with development-stage programs in xenotransplantation and regenerative medicine.
Description generated automatically from public sources; it may be inaccurate or out of date.
United Therapeutics Corporation: latest session data
Closing values for September 2, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
516.44 $
−4.73%
50 sessions
527.99 $
−6.81%
200 sessions
523.24 $
−5.97%
Session levels
s2
506.33
Support
s1
509.52
Support
pivot
513.63
Pivot
r1
516.82
Resistance
r2
520.93
Resistance
How to read it
In the September 2, 2026 session United Therapeutics Corporation closed lower at 492.02 $, −4.03% versus the previous session.
The price sits below every moving average observed: −4.73% against the 21-session average, −6.81% against the 50 and −5.97% against the 200.
The 14-period RSI reads 36.2, in neutral territory.
MACD stands at -5.343 against a signal line at -4.447: the histogram is negative (−0.896).
ADX reads 18.1, indicating weak directionality.
Levels computed on the latest session place supports at 509.52 and 506.33 $ and resistances at 516.82 and 520.93 $, around a pivot of 513.63.
The average daily range (ATR) is 14.322 $, or 2.91% of price.
Turnover was 1.4M shares, 270% of the 20-session average.
Over the last twelve months the price ranged between 477.01 and 609.35 $, and today stands −19.25% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the UTHR analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about United Therapeutics Corporation
How is United Therapeutics Corporation analysed technically?
Technical analysis of United Therapeutics Corporation is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for United Therapeutics Corporation?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to United Therapeutics Corporation?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to United Therapeutics Corporation it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.